Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 414
- Registration Number
- NCT05763082
- Locations
- 🇺🇸
DS Research, Louisville, Kentucky, United States
To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 447
- Registration Number
- NCT04944290
- Locations
- 🇺🇸
James D. Branch Ophthalmology, Winston-Salem, North Carolina, United States
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 657
- Registration Number
- NCT04155203
- Locations
- 🇺🇸
Palm Beach Research Center, West Palm Beach, Florida, United States
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 495
- Registration Number
- NCT04024072
- Locations
- 🇺🇸
James D. Branch Ophthalmology, Winston-Salem, North Carolina, United States
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 825
- Registration Number
- NCT03393494
- Locations
- 🇺🇸
Dermatology Consultants, High Point, North Carolina, United States
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 50
- Registration Number
- NCT03352323
- Locations
- 🇺🇸
J&S Studies, College Station, Texas, United States
Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 667
- Registration Number
- NCT02800148
- Locations
- 🇺🇸
Dermatology Consultants, High Point, North Carolina, United States
Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Padagis LLC
- Registration Number
- NCT02800824
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 486
- Registration Number
- NCT02795117
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 695
- Registration Number
- NCT02770365
- Locations
- 🇺🇸
Comprehensive Clinical Trials, LLC, West Palm Beach, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath